Maladies and mice. Pre-clinical vaccine development
Listen now
Description
Approaches used to target particularly tricky diseases to treat, such as malaria, HIV, Flu and TB. Whilst many of the world’s major diseases can be targeted by vaccines there is a drastic need for new or improved vaccines against a number of the most deadly including HIV, malaria, Tuberculosis and Influenza. In this episode we discuss why these diseases and others have been particularly difficult to target by vaccination and the approaches currently being used in the development of vaccines targeting them. Featuring guests, Lynda Coughlan and Rachel Tanner. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/
More Episodes
Clinical trials for vaccines: how they work and what's involved for volunteers. Testing novel vaccines in humans is the first step on a long route to licensure. Clinical trials are long, expensive but essential procedures designed to confirm both a vaccines safety but also its effectiveness. Here...
Published 10/19/15
The stringent processes that ensure new vaccines are clinic-ready Vaccines like any medicinal product need to be manufactured at the highest standard before they are allowed to be tested in humans. Achieving such standards take time, money and careful planning. In this episode we discuss the...
Published 10/19/15